Exploring the future of local vascular and inflammatory mediators

Articles in the same Issue

1. Exploring the future of local vascular and inflammatory mediators
2. Genetically altered animal models in the kallikrein-kinin system
3. The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy
4. Cross-talk of the renin-angiotensin and kallikrein-kinin systems
5. Which endothelium-derived factors are really important in humans?
6. Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells
7. Anti-inflammatory effects of kinins via microglia in the central nervous system
8. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma
9. Three-dimensional structure of an AMPA receptor without associated stargazin/TARP proteins
10. Dual antagonists of the bradykinin B₁ and B₂ receptors based on a postulated common pharmacophore from existing non-peptide antagonists
11. Generation and characterization of a humanized bradykinin B1 receptor mouse
12. The role of bradykinin B1 receptor on cardiac remodeling in stroke-prone spontaneously hypertensive rats (SHR-SP)
13. Molecular identification and pharmacological profile of the bovine kinin B₁ receptor
14. Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR)
15. Cathepsin B localizes to plasma membrane caveolae of differentiating myoblasts and is secreted in an active form at physiological pH